Patrick M. O’Neil - Publications, H-index & Citations

Patrick M. O’Neil

Department of Psychiatry and Behavioral Sciences

48H指数

174论文数

1.2W被引数

收录论文 39

发表时间

Correction: Quality of life improvements associated with weight loss using a novel shape-shifting hydrogel capsule: RESET study results 更正：使用新型变形水凝胶胶囊进行减肥所带来生活质量改善：RESET研究结果

International Journal of Obesity

IF3.8

2025-11-13

OAAI

Robert F. Kushner; Jamy D. Ard; Thomas A. Wadden; Patrick M. O’Neil; Harold E. Bays; Frank L. Greenway; John M. Jakicic; Holly R. Wyatt; Yael Kenan; Liora Cohen Asaraf; Donna H. Ryan

Quality of life improvements associated with weight loss using a novel shape-shifting hydrogel capsule: RESET study results 使用新型形状记忆水凝胶胶囊进行减肥所带来的生活质量改善：RESET研究的结果

International Journal of Obesity

IF3.8

2025-09-16

OAAI

Robert F. Kushner; Jamy D. Ard; Thomas A. Wadden; Patrick M. O’Neil; Harold E. Bays; Frank L. Greenway; John M. Jakicic; Holly R. Wyatt; Yael Kenan; Liora Cohen Asaraf; Ryan H. Ryan

Efficacy and safety of a novel oral hydrogel capsule in adults with overweight or obesity: the pivotal randomized RESET study

OBESITY

IF4.7

2025-02-04

OAAI

Ard, Jamy D.; Ryan, Donna H.; O'Neil, Patrick M.; Kushner, Robert F.; Wyatt, Holly R.; Bays, Harold E.; Greenway, Frank L.; Jakicic, John M.; Leonard, Sharon; Kenan, Yael; Ganon-Elazar, Eti; Wadden, Thomas A.

Patterns of Genetic Risk for Type 2 Diabetes Are Specific to Ancestry

DIABETES

IF7.5

2024-06-14

PREAI

Yurchishin, Marian L.; Fowler, Lauren A.; Gower, Barbara; Fernandez, Jose R.; O'Neil, Patrick M.

Pilot evaluation of a personalized commercial program on weight loss, health outcomes, and quality of life

TRANSLATIONAL BEHAVIORAL MEDICINE

IF3

2021-08-16

PREAI

Hales, Sarah B.; Schulte, Erica M.; Turner, Tonya F.; Malcolm, Robert; Wojtanowski, Alexis C.; Rethorst, Chad; Pinto, Angela M.; Foster, Gary D.; O'Neil, Patrick M.

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity The STEP 3 Randomized Clinical Trial Semaglutide vs安慰剂作为强化行为治疗的辅助手段对超重或肥胖成人体重的影响第三步随机临床试验

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

IF55

2021-04-13

499

OAAI

Wadden, Thomas A.; Bailey, Timothy S.; Billings, Liana K.; Davies, Melanie; Frias, Juan P.; Koroleva, Anna; Lingvay, Ildiko; O'Neil, Patrick M.; Rubino, Domenica M.; Skovgaard, Dorthe; Wallenstein, Signe O. R.; Garvey, W. Timothy

Vitamin D Supplementation and Prevention of Type 2 Diabetes

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2019-08-08

429

OAAI

Pittas, Anastassios G.; Dawson-Hughes, Bess; Sheehan, Patricia; Ware, James H.; Knowler, William C.; Aroda, Vanita R.; Brodsky, Irwin; Ceglia, Lisa; Chadha, Chhavi; Chatterjee, Ranee; Desouza, Cyrus; Dolor, Rowena; Foreyt, John; Fuss, Paul; Ghazi, Adline; Hsia, Daniel S.; Johnson, Karen C.; Kashyap, Sangeeta R.; Kim, Sun; LeBlanc, Erin S.; Lewis, Michael R.; Liao, Emilia; Neff, Lisa M.; Nelson, Jason; O'Neil, Patrick; Park, Jean; Peters, Anne; Phillips, Lawrence S.; Pratley, Richard; Raskin, Philip; Rasouli, Neda; Robbins, David; Rosen, Clifford; Vickery, Ellen M.; Staten, Myrlene

Body Weight Considerations in the Management of Type 2 Diabetes

ADVANCES IN THERAPY

IF4

2018-11-21

167

OAAI

Apovian, Caroline M.; Okemah, Jennifer; O'Neil, Patrick M.

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial semaglutide与利拉鲁肽和安慰剂对肥胖患者减肥的疗效和安全性比较: 一项随机，双盲，安慰剂和活性对照，剂量范围，2期试验

LANCET

IF88.5

2018-08-01

508

PREAI

O'Neil, Patrick M.; Birkenfeld, Andreas L.; McGowan, Barbara; Mosenzon, Ofri; Pedersen, Sue D.; Wharton, Sean; Carson, Charlotte Giwercman; Jepsen, Cecilie Heerdegen; Kabisch, Maria; Wilding, John P. H.

Description, utilisation and results from a telehealth primary care weight management intervention for adults with obesity in South Carolina

JOURNAL OF TELEMEDICINE AND TELECARE

IF3.2

2018-07-25

PREAI

Brown, Joshua D.; Hales, Sarah; Evans, T. Ed; Turner, Tonya; Sword, David O.; O'Neil, Patrick M.; Ballentine, Sara; Lovelace, Oscar; DuBose-Morris, Ragan Aleise

Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts

DIABETES CARE

IF16.6

2018-06-25

OAAI

LeBlanc, Erin S.; Pratley, Richard E.; Dawson-Hughes, Bess; Staten, Myrlene A.; Sheehan, Patricia R.; Lewis, Michael R.; Peters, Anne; Kim, Sun H.; Chatterjee, Ranee; Aroda, Vanita R.; Chadha, Chhavi; Neff, Lisa M.; Brodsky, Irwin G.; Rosen, Clifford; Desouza, Cyrus V.; Foreyt, John P.; Hsia, Daniel S.; Johnson, Karen C.; Raskin, Philip; Kashyap, Sangeeta R.; O'Neil, Patrick; Phillips, Lawrence S.; Rasouli, Neda; Liao, Emilia P.; Robbins, David C.; Pittas, Anastassios G.

Perceptions of Barriers to Effective Obesity Care: Results from the National ACTION Study

OBESITY

IF4.7

2017-10-31

206

OAAI

Kaplan, Lee M.; Golden, Angela; Jinnett, Kimberly; Kolotkin, Ronette L.; Kyle, Theodore K.; Look, Michelle; Nadglowski, Joseph; O'Neil, Patrick M.; Parry, Thomas; Tomaszewski, Kenneth J.; Stevenin, Boris; Lilleore, Soren Kruse; Dhurandhar, Nikhil V.

Characteristics of Weight Loss Trajectories in a Comprehensive Lifestyle Intervention

OBESITY

IF4.7

2017-10-31

OAAI

Marek, Ryan J.; Coulon, Sandra M.; Brown, Joshua D.; Lydecker, Janet A.; Marek, Scott; Malcolm, Robert; O'Neil, Patrick M.

Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials

DIABETES OBESITY & METABOLISM

IF5.7

2017-07-21

OAAI

O'Neil, Patrick M.; Aroda, Vanita R.; Astrup, Arne; Kushner, Robert; Lau, David C. W.; Wadden, Thomas A.; Brett, Jason; Cancino, Ana-Paula; Wilding, John P. H.

Randomized Controlled Trial of a Nationally Available Weight Control Program Tailored for Adults with Type 2 Diabetes

OBESITY

IF4.7

2016-11-02

OAAI

O'Neil, Patrick M.; Miller-Kovach, Karen; Tuerk, Peter W.; Becker, Lynne E.; Wadden, Thomas A.; Fujioka, Ken; Hollander, Priscilla L.; Kushner, Robert F.; Garvey, W. Timothy; Rubino, Domenica M.; Malcolm, Robert J.; Weiss, Daniel; Raum, William J.; Salyer, Jonny L.; Hermayer, Kathie L.; Rost, Stephanie L.; Veliko, Jan L.; Sora, Nicoleta D.

Early Weight Loss with Liraglutide 3.0 mg Predicts 1-Year Weight Loss and is Associated with Improvements in Clinical Markers

OBESITY

IF4.7

2016-11-02

OAAI

Fujioka, Ken; O'Neil, Patrick M.; Davies, Melanie; Greenway, Frank; Lau, David C. W.; Claudius, Birgitte; Skjoth, Trine Vang; Jensen, Christine Bjorn; Wilding, John P. H.

EFFECTS OF LIRAGLUTIDE 3.0 MG ON WEIGHT AND RISK FACTORS IN HISPANIC VERSUS NON-HISPANIC POPULATIONS: SUBGROUP ANALYSIS FROM SCALE RANDOMIZED TRIALS

ENDOCRINE PRACTICE

IF4.6

2016-11-01

PREAI

O'Neil, Patrick M.; Garvey, W. Timothy; Gonzalez-Campoy, J. Michael; Mora, Pablo; Ortiz, Rafael Violante; Guerrero, German; Claudius, Birgitte; Pi-Sunyer, Xavier

Timing the Discussion of Antiobesity Medications During Obesity Treatment

OBESITY

IF4.7

2016-09-02

OAAI

Rebello, Candida J.; O'Neil, Patrick M.; Horn, Deborah B.; Greenway, Frank L.

Effects on cardiovascular risk factors of weight losses limited to 5-10 %

TRANSLATIONAL BEHAVIORAL MEDICINE

IF3

2015-11-04

OAAI

Brown, Joshua D.; Buscemi, Joanna; Milsom, Vanessa; Malcolm, Robert; O'Neil, Patrick M.